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Abstract
Background: Integrins, cell-surface receptors that mediate adhesive interactions between cells
and the extracellular matrix (ECM), play an important role in cancer progression. Expression of the
vitronectin receptor αvβ3 integrin correlates with increased invasive and metastatic capacity of
malignant melanomas, yet it remains unclear how expression of this integrin triggers melanoma
invasion and metastasis.
Results: Two melanoma cell lines C8161.9 and M14 both express high levels of αvβ3 integrin and
adhere to vitronectin. However, only the highly metastatic C8161.9 cells are capable of invading
vitronectin-enriched Matrigel in an αvβ3-depenent manner. Elevated levels of PKCα and PKCδ, and
activated Src were detected specifically in the highly metastatic melanoma cells, but not in the low
metastatic M14 cells. Inhibition of Src or PKC activity suppressed αvβ3-dependent invasion.
Furthermore, over expression of Src or PKCα and PKCδ was sufficient to confer αvβ3-dependent
invasiveness to M14 cells. Stress fiber formation and focal adhesion formation were almost
completely absent in C8161.9 cells compared to M14 cells. Inhibition of Src signaling was sufficient
to restore normal actin architecture, and resulted in decreased p190RhoGAP phosphorylation and
enhanced RhoA activity. Src had no effect on Rac activity. Loss of PKCα expression, but not PKCδ,
by siRNA inhibited Rac and PAK activity as well as invasiveness. Loss of PKCα restored focal
adhesion formation and partially restored stress fiber formation, while loss of PKCδ primarily
restored stress fibers.
Conclusion:  The misregulated expression of PKCα and PKCδ and elevated Src activity in
metastatic melanoma cells is required for efficient αvβ3-mediated invasion. PKCα and Src enhance
αvβ3-mediated invasion in part by increasing the GTPase activity of Rac relative to RhoA. PKCα
influences focal adhesion formation, while PKCδ controls stress fibers.
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Background
The development of metastatic melanoma in human
patients is marked by the progression from a noninvasive
radial growth phase to a vertical growth phase, where
tumor cells begin to penetrate through the dermal layer
and into the subcutaneous tissues [1]. Induced expression
of αvβ3 integrin is coincident with and present only on
vertical growth phase melanomas [2,3]. αvβ3 is not
expressed on melanocytes, nevi, or radial growth primary
melanomas in vivo. It is present in melanocyte precursors,
i.e. neural crest cells, as they migrate and populate the skin
during early development. The M21-L human melanoma
cell line, lacking αvβ3 integrin expression, was shown to
have a dramatically reduced ability to induce tumors and
metastases in nude mice. Expression of αvβ3 in M21-L
cells restored their tumorigenic properties [4]. Further-
more, subcutaneous growth of αvβ3-positive M21
melanoma cells in nude mice was reduced significantly by
αv-specific blocking antibodies. Ectopic expression of
αvβ3 in radial growth melanomas isolated from patients
is sufficient to confer enhanced growth and invasive prop-
erties to those tumor cells [5]. Thus αvβ3 integrin plays an
important role in both tumor growth and metastasis.
However, the precise mechanisms by which αvβ3 integrin
expression promotes melanoma growth and metastasis
remain poorly understood.
αvβ3 integrin functions as an adhesion receptor on the
surface of cells and binds with highest affinity to the extra-
cellular matrix (ECM) ligand vitronectin (VN). Binding is
mediated via RGD peptides present in VN. RGD peptides
are also present in other ECM proteins, such as fibronectin
and fibrinogen, and correspondingly αvβ3 is able to
mediate adhesion to these ECM proteins as well. Engage-
ment of αvβ3 integrin upon adhesion to matrix, like the
engagement of most integrins by the ECM, triggers intrac-
ellular signaling [6]. The initial attachment of cells to
matrix induces the formation of early integrin focal con-
tact structures or nascent adhesions that require signaling
from Src and include the integrin binding protein talin,
ERM proteins, cortactin, and other signaling molecules
such as PKC and the Rho GTPase Rac [7,8]. With time the
focal complexes mature into integrin-rich focal adhesions
containing structural proteins such as vinculin, paxillin,
α-actinin, and FAK, followed by the emergence of bun-
dled actin stress fibers which project from the focal adhe-
sions. The maintenance of these structures is mediated by
signaling to the small GTPase RhoA [9]. For matrix adher-
ent cells to migrate they must disrupt their focal adhesions
and actin stress fibers, and loosen their adhesion to the
ECM [10]. As the cell reattaches its loosened membrane
the early focal contact structures are again reformed. A
hallmark of highly migratory cells is diminished focal
adhesions and stress fibers and the predominance of the
early focal contact structures. Maintenance of these struc-
tures is regulated by cdc42 and Rac [9].
Formation of the different integrin adhesion structures is
tightly controlled by signaling molecules that target the
structural proteins involved in their development. The
nonreceptor tyrosine kinase Src has been shown to physi-
cally interact with the cytoplasmic domain of the β3
integrin tail and is activated immediately upon integrin
engagement [11]. Loss of Src kinases dramatically impairs
integrin-mediated focal contact assembly and over expres-
sion of active Src prevents focal adhesion and stress fiber
formation [12]. Structural and regulatory proteins within
focal contacts and focal adhesions, such as cortactin,
ERMs, Rho GEFs, FAK, paxillin, vinculin, and Rho GAPs,
are known Src kinase substrates. Thus Src plays a pivotal
role in integrin-mediated adhesion and signaling. A few
reports have linked increased Src kinase signaling and
expression with the development of metastatic
melanoma. Elevated Src activity, over expressed Yes, and
active Fyn have all been reported in melanoma cell lines
[13-15]. Src kinase targets identified in melanoma cells
include cortactin, tenascin-C, Tks5, and Stats [15-18].
Increased Src signaling in melanoma cells was associated
with increased growth, survival, and metastasis and in two
cases increased Src signaling was linked to αvβ3 integrin
[17,19].
The most well characterized substrate of the serine/threo-
nine kinase PKC, MARCKS, is an actin binding protein
localized within cortical actin structures at the cell mem-
brane [20]. Adhesion to matrix results in PKC-dependent
phosphorylation and removal of MARCKS from the actin
structures. Displacement of MARCKS is thought to be
important for reorganization of the cortical actin required
for the assembly of focal contacts. Changes in PKC expres-
sion have been implicated in melanoma progression.
PKCα was shown to be highly expressed in some meta-
static melanomas and was crucial for melanoma metasta-
sis in vivo [21,22]. However, some melanoma cell lines do
not express PKCα due to a deletion in the gene [23].
PKCβ, which is involved in maintaining melanocyte dif-
ferentiation, is often lost in metastatic melanoma
[24]javascript:PopUpMenu2_Set(Menu7678596);. On
the other hand over expression of PKCδ, in at least one
melanoma cell line, correlated with increased metastasis
[25]. The extent to which αvβ3 integrin in particular acti-
vates or cooperates with PKC to regulate melanoma
metastasis has not been investigated and which PKC iso-
form may be responsible for αvβ3-dependent melanoma
invasion and metastasis has not been determined.
While screening the expression levels of PKC and Src in
various melanoma cell lines we discovered a correlation
between high PKCα and PKCδ levels and Src activity, andCell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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the metastatic potential of several melanoma cell lines. In
the study presented here we tested the hypothesis that ele-
vated PKC levels and Src kinase activity are responsible for




αvβ3 (LM609) and β5 (P1F6) blocking integrin antibod-
ies [26,27] were purchased from Chemicon. The Src 327
monoclonal antibody has been described previously [28].
Src phospho-specific antibody, Y418, was purchased from
Biosource. Antibodies to PKCα, PKCδ, PKCε, Rac1, and
RhoA were obtained from BD Transduction Labs. PAK
and phospho-PAK antibodies were purchased from Cell
Signaling Technology. p190RhoGAP antibodies came
from Santa Cruz. Alexafluor 488 goat anti-mouse and
Alexafluor 546 phalloidin were from Molecular Probes
and Hoechst 33258 was from Sigma.
Cell lines
The metastatic melanoma cell line C8161.9 [29],
obtained from Dr. Danny Welch, (University of Alabama,
Birmingham, Alabama, USA) was grown in DMEM/F12
(Invitrogen) supplemented with 2 mM L-glutamine, 50
U/ml penicillin, 50 ug/ml streptomycin/ml, 0.1 mM
NEAA, 1 mM NaPyruvate, and 5% fetal bovine serum
(FBS). M14 melanoma cells (Dr. Han-Mo Koo, Van Andel
Institute) were grown in RPMI-1640 (Invitrogen) supple-
mented with 2 mM L-Glutamine, Gentamicin, and 5%
FBS. A375 metastatic melanoma cells were obtained from
ATCC and grown in MEM Hanks (Invitrogen) supple-
mented with 50 U of penicillin, 50 ug/ml streptomycin,
0.1 mM NEAA, 1 mM NaPyruvate, and 10% FBS. HUVECS
were obtained from Cascade Biololgicals and normal cul-
tured primary melanocytes, NHEM, were purchased either
from Clonetics or Cascade. Both cell lines were grown in
media supplied by their respective companies. DF1
chicken fibroblast cell line [30] (Dr. Bart Williams, Van
Andel Institute) was grown in DMEM (Invitrogen) supple-
mented with 2 mM L-Glutamine, 1 mM NaPyruvate, 50
U/ml penicillin, 50 ug/ml streptomycin, and 10% heat
inactivated FBS. Stable C8161.9 and M14 cell lines
expressing tVA, the chicken retrovirus receptor, were
established as previously described [31].
Inhibitors
Src inhibitors PD173955, PD180970, and SU6656, and
PKC inhibitors bisindolylmaleimide and 12-O-tetrade-
canoylphorbol 13-acetate (TPA) were purchased from
Calbiochem. Cells were treated overnight with 100 ng/ml
TPA or for 30 minutes prior to use with 10 uM bisindolyl-
maleimide, 10 uM PD173955 or PD180970, or 2 uM
SU6656.
Transient Transfections
One ug of pcDNA-RhoA-Q61L [32] was transiently
cotransfected with 1 ug pCMV-GFP into C8161.9 cells
with Lipofectamine Plus (Invitrogen) using the recom-
mended protocol. 48 hours after transfection cells were
plated on matrix for immunofluorescent staining.
Virus Generation and Infections
pGST-Src and pGST-SrcK295M [33] were obtained from
Dr. Sara Courtneidge (Burnham Institute, San Diego, Cal-
ifornia, USA) and subcloned via EcoRI into pENTR3c vec-
tor (Gateway, Invitrogen) and then recombined into the
Gateway modified pDEST-RCAS retroviral vector [34].
Full length rabbit PKCα and mouse PKCδ cDNAs from Dr.
Shigeo Ohno (Yokohama City University, Japan) were
subcloned via EcoRI into Bluescript cloning vector (Strate-
gene) to generate pBS-PKCα and pBS-PKCδ. PKCα and
PKCδ were released with NotI and ClaI and subcloned
into pRCASBP-Y retroviral vector [34]. RCAS-Src, RCAS-
SrcK295M, RCAS-PKCα, and RCAS-PKCδ were transfected
into DF1 chicken fibroblasts and retroviruses generated as
previously described [30]. C8161.9 cells or M14 cells
expressing tVA were infected with virus (~1 × 107 IU/100
mm plate) in the presence of 8 ug/ml Polybrene (Invitro-
gen). Seventy-two hours after infection, cells were selected
in 7 ug/ml of puromycin (Invitrogen) or 400 ug/ml G418
(Invitrogen) for 2 weeks. Surviving cells were pooled and
maintained in standard DMEM/F12 growth medium.
siRNAs
PKC isoform-specific siRNAs sequences (IDT) were as fol-
lows: PKCδ si1δ: 5'-UGGCGCCGUUCCUGCGCAU-3',
PKCα si2α: 5'-CCUGCGAUAUGAACGUUCA-3', and
si3α: 5'-AAGGCUUCCAGUGCCAAGA-3'. The scrambled
siRNA control sequence was 5'-ACUACCGUUGU-
UAUAGGUG-3'. All sequences were blasted using
BLASTN and contained no homology to any other known
human genes. C8161.9 cells at 30–50% confluency in 100
mm tissue culture dishes were starved (DMEM/F12 +
0.1% FBS) 24 hours prior to transfection. Cells were trans-
fected with 20 nM siRNAs with SiLentFect (Bio-Rad) as
suggested by the manufacture. The cells were allowed to
recover in growth media supplemented with 2% FBS for
24 hours. Cells were then placed in starvation media for
an additional 48 hours before use in adhesion assays.
FACS
Serum starved cells were removed from tissue culture
plates by trypsinization and rinsed with soybean trypsin
inhibitor (Invitrogen). Cells resuspended in PBS + 0.1%
BSA at 1 × 106  to 1 ×107 cells/ml were incubated with 5
ug/ml of αvβ3 or β5 integrin antibodies for 1 hour at 4°C.
Cells were washed with PBS and incubated with FITC-con-
jugated secondary antibodies in PBS+0.1% BSA for 1 hour
at 4°C. Cells were washed with PBS, fixed with 1% para-Cell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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formaldehyde in PBS at 4°C for 20 minutes, washed in
PBS, and analyzed by Fluorescent Activated Cell Sorting
(FACS) with the FACSCalibur (Becton Dickinson) and
CellQuest (Becton Dickinson).
Matrix Adhesion
For assays done on extracellular matrices, cells were pre-
pared as previously described [35]. Briefly, cells were
growth factor-starved for 48 hours, trypsinized, treated
with soybean trypsin inhibitor (Invitrogen), washed in
PBS, and suspended in serum-free medium for 30–60
minutes. Cells were then plated on tissue culture plates or
sterilized coverslips coated with 5 ug to 10 ug/ml vitronec-
tin (Chemicon) and blocked with 1% BSA (Sigma). Sus-
pension controls were maintained at 37°C. One to two
hours after plating on matrix cells were either lysed for
biochemical analysis or immunostained.
Immunoblotting
For biochemical analyses cells were lysed either in Triton-
X (50 mM Tris pH 7.5, 100 mM NaCl, 0.5 mM EDTA, 1%
TritonX-100, 50 mM NaF, 50 mM β-glycerophosphate, 5
mM sodium pyrophosphate, 1 mMNa3VO4, 1 mM PMSF,
100 U/ml aprotinin, 10 ug/ml pepstatin, and 10 ug/ml
leupeptin) or RIPA (10 mM Tris pH 7.2, 158 mM NaCl, 1
mM EDTA, 0.1% SDS, 1% NaDOC, 1% Triton-X100, 1
mMNa3VO4, 1 mM PMSF, 100 U/ml aprotinin, 10 ug/ml
pepstatin, and 10 ug/ml leupeptin) buffers. For immuno-
precipitation, 500 to 1000 ug/ml protein was incubated
with the appropriate antibodies for 3 hours at 4°C with
either protein A- or protein G-conjugated agarose beads
(Pierce) to capture the complexes. Washed immunopre-
cipitates were resuspended in 2× SDS sample buffer con-
taining 10% β-mercaptoethanol. All samples were
subjected to SDS-polyacrylamide gel electrophoresis, and
transferred to a polyvinylidene difluoride membrane
(PVDF). The PVDF membranes were blocked with 5%
BSA in Tris-buffered saline containing 0.1% Tween 20
(TBST) for 2 hours, followed by 2 hour incubation with
the appropriate primary antibodies in 5% BSA/TBST. After
washing, blots were incubated with a horseradish peroxi-
dase-conjugated secondary antibody for 1 hour in 5%
BSA/TBST, visualized with a chemiluminescence reagent,
and captured by a CCD camera in a Bio-Rad Chemi-Doc
Imaging System and quantified using Quantity One soft-
ware (Bio-Rad). Blots were stripped in low-pH 2% SDS at
65°C for 60 minutes, rinsed and reprobed for total levels
of protein in the immunoprecipitates or cell lysates.
Migration and Invasion assays
Boyden chambers inserts containing Matrigel in the upper
chamber were purchased from Becton-Dickinson. The
lower side of the porous membrane in the Boyden inserts
was treated with 10 ug/mL vitronectin overnight at room
temperature. This results in a vitronectin coating on the
lower side of the membrane as well as some vitronectin
seeping into the Matrigel above. After coating, the lower
side of the membranes were washed with PBS and
blocked with 1% BSA for 2–4 hours at 37°C while the
Matrigel in the upper chamber was rehydrated with
DMEM. Serum starved cells were placed in suspension in
serum free medium. Inhibitors or blocking antibodies
were added to suspension cells prior to plating in cham-
bers and 1.5 × 105 to 2 × 105 cells were added to the top
chamber in the absence of serum. Medium without serum
was added to the lower chambers. All chambers were incu-
bated in 5% CO2 at 37°C for 72 hours. Chamber inserts
were rinsed with PBS and then cells were stained and fixed
with crystal violet/formalin mixture (Chemicon) for 20
minutes. Any cells remaining in the top chamber were
removed with a cotton applicator tip. Cells having
migrated to the bottom chamber and adhering to the
lower side of the membrane were visualized with Nikon
Eclipse TE300 Epi-flourescence Microscope using a 10×
objective. Pictures were taken with the Hamamatzu Dig-
ital CCD camera using OpenLab imaging software
(Improvision) and the RGB Colour Merge Automator
(OpenLab). Five pictures of each well were taken and the
cells in each image were counted. All assays were repeated
at least 3 times.
Rac and Rho activation
Rho pull-down assays were carried out essentially as
described [36] and the Rac pull-down protocol was
adapted from del Pozo et al [37]. GST-RBD (rhotekin
binding domain) and GST-PBD (PAK binding domain)
protein expression was induced with 0.5 mM Isopropyl-β-
D-thiogalactopyranoside (IPTG) for 2 hr at 30°C in 4 lit-
ers of culture or for 3–4 hr at 37°C in 200 ml respectively.
GST-RBD bacteria were resuspended in 40 ml cold lysis
buffer (50 mM Tris, pH 7.5, 1% Triton X-100, 150 mM
NaCl, 5 mM MgCl2, 1 mM DTT, 10 ug/ml aprotinin, 10
μg/ml leupeptin and 1 mM PMSF). GST-PBD bacteria
were resuspended in 10 ml cold lysis buffer (50 mM Tris,
pH 7.5, 150 mM NaCl, 10% glycerol, 2 mM EDTA, 10 ug/
ml aprotinin, 10 ug/ml leupeptin and 1 mM PMSF). Sus-
pensions were sonicated and clarified lysates were mixed
with 0.6 ml glutathione beads (Sigma) and rotated at 4°C
for 60 min. The GST-RBD beads were washed six times
with 12 ml wash buffer (50 mM Tris, pH 7.5, 0.5% Triton
X-100, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 1 ug/ml
aprotinin, 1 ug/ml leupeptin and 0.1 mM PMSF) and
GST-PBD beads were washed three times with 12 ml lysis
buffer supplemented with 0.5% NP-40 then washed 3×
with storage buffer (50 mM Tris pH7.5, 150 mM NaCl,
10% glycerol, 5 mM MgCl2, 1 mM DTT). Beads were
resuspended in 1 ml wash buffer with 10% glycerol and
used immediately for pull-downs. Purified GST-RBD and
GST-PBD proteins were quantified using a 12% SDS PAGE
and BSA standards for comparison. These preparationsCell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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typically yielded between 20–30 ug protein per 20 ul aliq-
uot of bead suspension.
Following adhesion to matrix cells were placed on ice and
washed twice with ice-cold Tris-buffered saline (50 mM
Tris, pH7.4, 150 mM NaCl, 10 mM MgCl2). For Rho
assays cells were lysed in 500 ul of cold Rho lysis buffer
(50 mM Tris, pH 7.2, 1% Triton X-100, 0.5% sodium
deoxycholate, 0.1% SDS, 500 mM NaCl, 10 mM MgCl2,
10 μg/ml each of leupeptin and aprotinin, and 1 mM
PMSF). For Rac assays, cells were lysed in 500 ul of cold
Rac lysis buffer (50 mM Tris pH 7.4, 10 mM MgCl2, 1%
Triton-X, 10% glycerol, 500 mM NaCl, 0.1% DOC, 10 ug/
ml leupeptin, 10 ug/ml aprotinin, 10 ug/ml pepstatin, 2
mM PMSF). 300–500 ug of lysates were combined with
20 ul of bead suspension and rotated at 4°C for 60 min.
Bead suspension was washed four times with 600 μl ice
cold buffer containing 50 mM Tris, pH 7.2, 1% Triton X-
100, 150 mM NaCl, 10 mM MgCl2, and 10 ug/ml each of
leupeptin and aprotinin, and 0.1 mM PMSF. Samples
were boiled 10 min in SDS sample buffer and separated
on 12% Tris-Glycine SDS PAGE gels. Proteins were trans-
ferred to PVDF membrane for immunoblotting with
RhoA or Rac antibodies.
ECL images were captured by a CCD camera in a Bio-Rad
Chemi-Doc Imaging System and the intensity of the acti-
vated RhoA and total RhoA ECL signals were quantified
using Quantity One software (Bio-Rad). Extent of RhoA
activation was normalized to total RhoA for each sample.
Data were expressed as the fold in increase in RhoA acti-
vation compared to control or untreated samples.
Immunofluorescent staining
Sterilized cover-slips (Fisher) were coated with 5–10 μg/
ml vitronectin O/N at 4°C, blocked in PBS + 1% BSA for
1–2 hours at 37°C, and then washed with PBS prior to
plating 2–3 × 105 suspended cells in serum-free medium.
After incubation at 37°C for 45 minutes cells were fixed
with 4% paraformaldehyde in PBS at 4°C for 20 minutes.
Cells were permeabilized with TBS (10 mM Tris, pH 8.0,
150 mM NaCl) + 0.5% TritonX-100 for 10 minutes at
room temperature and blocked with 2% BSA/TBS-T for 20
minutes at room temperature. Cells were then incubated
at room temperature with primary antibody and Phalloi-
din 546 in 2% BSA/TBS-T for 60 minutes and then incu-
bated with Alexaflour 488 goat anti-mouse in 2% BSA in
TBS-T for 60 minutes. Nuclei were stained with Hoechst
for 5 minutes at room temperature. Cover-slips were
mounted onto slides in 50% glycerol. Cells were visual-
ized with Nikon Eclipse TE300 Epi-flourescence Micro-
scope using a 60× oil immersion objective. Pictures were
taken with the Hamamatzu Digital CCD camera using
OpenLab imaging software (Improvision).
Results
Vitronectin integrin expression in metastatic melanoma 
cells
The primary ligand for αvβ3 is vitronectin (VN); however,
another integrin, αvβ5, also binds VN. To determine
which integrin is responsible for the biological effects
mediated by adhesion to VN, αvβ3 and αvβ5 integrin
expression was measured in the melanoma cells. The cell
surface levels of αvβ3 and αvβ5 in cultured melanocytes
and in a non-invasive cell line, M14 [38], and a highly
metastatic melanoma cell line, C8161.9 [29], were quan-
tified by FACS. Irrespective of their metastatic potential,
both melanoma cell lines expressed similar levels of αvβ3,
while normal cultured melanocytes and HUVECs (posi-
tive control) expressed over 2 times more αvβ3. On the
other hand, the more highly metastatic melanoma cell
line, C8161.9, expressed over 2× higher levels of αvβ5
than M14 (Figure 1A). To determine which integrin is
required for the migratory and invasive properties of the
melanoma cell lines, cells were treated with or without VN
integrin-blocking antibodies [26,27] or IgG and their abil-
ity to invade and migrate through vitronectin-enriched
Matrigel to the lower chamber of a Boyden chamber in the
absence of serum or growth factors was evaluated. M14
and normal melanocytes both failed to invade through
VN/Matrigel, while invasion of the highly metastatic
C8161.9 cells was dramatically diminished in the pres-
ence of αvβ3, but not αvβ5 blocking antibodies (Figure
1B). If VN is omitted C8161.9 cells are unable to invade.
Thus, expression of αvβ3 is required for invasion of highly
metastatic melanoma cells. However, αvβ3 expression
alone is not sufficient, since αvβ3 is expressed on both
M14 and normal cultured melanocytes and these cells
were unable to invade. Therefore, additional signaling
events must also be required. These signaling events must
be intrinsic to the cells, since no exogenous growth fac-
tors, serum, or additional external stimuli other than
extracellular matrix (ECM) proteins, were added to the
invasion assays.
Src regulates invasion of metastatic melanoma cells
αvβ3 integrin is a strong activator of the nonreceptor tyro-
sine kinase Src [11], which is known to regulate cell migra-
tion and invasion [39]. Therefore, to determine whether
Src is required for the invasive properties of C8161.9 cells,
the levels of Src protein and its activity were first measured
by immunoblotting of cell extracts from normal melano-
cytes, M14, and C8161.9 cells after adhesion to VN. There
were no significant differences in total levels of Src protein
between these cell lines; however, the level of activated Src
(as measured by phosphorylation at Y418) was dramati-
cally increased in the highly metastatic C8161.9 cells (Fig-
ure 2A). A similar decrease in phosphorylation at Y529
was also observed (data not shown). Strikingly this
increase in Src activity occurred independently of integrinCell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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αvβ3 integrin-dependent invasion of C8161.9 cells Figure 1
αvβ3 integrin-dependent invasion of C8161.9 cells. A) Cell surface expression levels of αvβ3 (clear bar) and αvβ5 (black 
bar) integrins in two metastatic melanoma cell lines, C8161.9 and M14-mel, normal cultured melanocytes (NHEM), and the 
endothelial cell line HUVEC, were measured using FACS after surface labeling with fluorescently-labeled anti-integrin antibod-
ies. B) Vitronectin-induced Matrigel invasion of C8161.9, M14, or normal cultured melanocytes (NHEM) in Boyden chambers in 
the absence of serum or growth factors was assessed in the absence (IgG) or presence of anti-integrin blocking antibodies 
(anti-αvβ3 or anti-αvβ5). In the absence of vitronectin (no VN), cells were unable to invade the Matrigel.Cell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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Figure 2 (see legend on next page)Cell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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engagement, as Src activity was high even in cells placed
in suspension. Next, Src activity was inhibited in C8161.9
cells and αvβ3-dependent invasion was measured. Over
expression of a dominant interfering form of Src
(SrcK295M) [33] or treatment with two Src inhibitors dra-
matically reduced C8161.9 cell invasion (Figure 2B). Over
expression of wild type Src caused a 50% increase in inva-
sion. Normal cultured melanocytes and M14, both
express αvβ3 integrin (Figure 1A); however, neither have
high levels of active Src. Thus, constitutive activation of
Src, in combination withαvβ3, is required for invasion by
highly metastatic melanoma cells.
PKC regulates invasion of metastatic melanoma cells
Elevated expression of PKC has been shown to be associ-
ated with metastatic melanoma [21,22]. Highly metastatic
melanoma cells may also require PKC for αvβ3-mediated
invasion. The two highly invasive cell lines, C8161.9 and
A375, expressed high levels of both PKCα and PKCδ com-
pared to the less invasive melanoma cell line M14 and
normal cultured melanocytes (Figure 2C). PKC activity
was inhibited either by treatment with the PKC-specific
inhibitor bisindolylmaleimide, or down regulation of
PKC expression by long term treatment with TPA. Under
these conditions, αvβ3-mediated invasion of C8161.9
cells was inhibited 5–10 fold (Figure 2D). Thus, PKC
activity is required for invasion of C8161.9 cells.
Focal adhesion and stress fiber formation is aberrant in 
metastatic melanoma cells
Adhesion of normal cultured melanocytes or M14
melanoma cells to VN induced the formation of multiple
stress fibers and large focal adhesion complexes from
which the stress fibers emanated (Figure 3A). However,
adhesion of C8161.9 cells to VN failed to induce stress
fiber formation and the number and size of focal adhe-
sions were dramatically reduced. Since RhoA has been
shown to regulate the formation of stress fibers and focal
adhesions, RhoA signaling may be impaired in C8161.9
cells. To test this C8161.9 cells were transiently cotrans-
fected with a constitutively active form of RhoA and GFP.
Only the three cells expressing green GFP (i.e. transfected
with and expressing constitutively active RhoA Q61L) dis-
played prominent stress fibers (Figure 3B). The surround-
ing cells (asterisks) not expressing GFP and RhoA Q61L
do not have prominent stress fibers. Src has been shown
to be a negative regulator of RhoA activity [40]. Therefore,
it is possible that the high levels of Src activity in C8161.9
cells may be inhibiting RhoA activity. Indeed, inhibition
of Src with the specific inhibitor SU6656 or over expres-
sion of the K295M Src dominant interfering mutant was
sufficient to induce stress fibers and increase focal adhe-
sion formation (Figure 3C). Thus, the aberrant stress fiber
and focal adhesion formation in C8161.9 cells plated on
VN is likely due to the constitutively high level of active
Src, which effectively down regulates RhoA activity.
Src negatively regulates RhoA activity in metastatic 
melanomacells
To further verify that Src is regulating RhoA activity, RhoA
activity was measured in C8161.9 cells plated on VN using
GST-RBD pull-down assays. Inhibition of Src activity with
the Src-specific inhibitor SU6656 resulted in a 2.1-fold
increase in RhoA activation after plating on VN (Figure
4A). Similarly, expression of the dominant interfering
mutant of Src (SrcK295M) increased RhoA activity 2.5-
fold compared to control cells plated on VN (Figure 4B).
Conversely, over expression of wild type Src decreased
RhoA activation 1.4-fold. The Rho-specific GAP,
p190RhoGAP, is known to be activated by adhesion to
matrix and its activity is regulated by Src-dependent tyro-
sine phosphorylation [41-43]. Activation of p190RhoGAP
by active Src in C8161.9 cells could be responsible for the
inhibition of RhoA activity following adhesion to matrix.
Src and PKC are required for αvβ3-dependent invasion Figure 2 (see previous page)
Src and PKC are required for αvβ3-dependent invasion. A) C8161.9, M14, or normal cultured melanocytes (NHEM) 
were placed in suspension (S) or plated on vitronectin (VN). The level of Src activity present in Src immunoprecipitates was 
measured by immunoblotting with rabbit anti-phospho-specific antibodies to the activation loop phosphorylated tyrosine, Y418 
(Y418P Blot). Total levels of Src in the same immunoprecipitates were measured by immunoblotting stripped blots with total 
mouse anti-Src antibodies (Src Blot). The mouse immunoglobulin band in the immunoprecipitates is indicated (IgG). B) 
C8161.9 cells expressing the avian retroviral receptor tVA were left uninfected (C), or infected with avian retroviruses 
expressing GFP (G), wild type Src (WT) or a dominant interfering Src mutant (K-M or K295M). Levels of Src expression were 
monitored by immunoblotting of whole cell lystates (Src). Vitronectin-induced Matrigel invasion of Src-inhibited cells was quan-
tified. Data represents 6 independent experiments. C8161.9 cells were also treated with two Src inhibitors, PD173955 (PD-R) 
or PD180970 (PD-S) and the extent of VN-induced invasion in the absence of serum or growth factors was assessed. C) Three 
melanoma cells lines, C8161.9, A375, M14, and normal cultured melanocytes (NHEM) were untreated (-) or pretreated (+) 
with 100 nM TPA for 16 hours to down regulate expression of classical and novel PKCs. The levels of PKCα, PKCδ, and PKCε 
expression were measured by immunoblotting of whole cell extracts. Equal levels of cell extract were loaded and probed by 
immunoblotting with specific antibodies. D) C8161.9 cells were pretreated with DMSO, TPA for 16 hours, or bisindolylmale-
imide and vitronectin-induced Matrigel invasion in the absence of serum or growth factors was assessed and quantified.Cell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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Treatment of C8161.9 cells with the Src inhibitor SU6656
or expression of mutant Src blocked VN-induced tyrosine
phosphorylation of p190RhoGAP (Figure 4C, D). All
together these data demonstrate that αvβ3-mediated
adhesion of highly metastatic melanoma cells to its extra-
cellular matrix substrate VN results in Src-dependent
phosphorylation and up-regulation of p190RhoGAP
activity, a Src-dependent decrease in RhoA activity and
stress fiber and focal adhesion formation, and a Src-
dependent increase in αvβ3-mediated invasion. Thus, the
elevated Src activity in the highly invasive metastatic
melanoma cells is required for effective αvβ3-mediated
invasion and functions in part to limit RhoA activity,
which may favor a more migratory phenotype.
PKCα positively regulates Rac activity in 
metastaticmelanoma cells
Previous studies have demonstrated that the relative dif-
ferences in RhoA and Rac activity in cells reflects the net
migratory phenotype [44]. Cells with high Rac, but low
RhoA, are more migratory, while cells with high RhoA,
but low Rac, are less migratory. Given that C8161.9 cells
have low RhoA activity and their adhesion and actin struc-
tures resemble those seen in cells with high Rac activity,
elevated Rac activity may account in part for the increased
invasiveness of C8161.9 cells. The total levels of Rac pro-
tein and Rac activity were measured and compared
between C8161.9 and M14 cells. Using cell lysates con-
taining comparable levels of Rac expression and normal-
izing for total Rac levels, 2.5–3-fold more Rac activity is
present in C8161.9 cells than M14 cells (Figure 5A).
One possibility is that the elevated Src activity in C8161.9
cells not only inhibits RhoA, but also increases Rac activ-
ity. To test this hypothesis, Src activity was inhibited in
C8161.9 cells and the effects on Rac activity monitored.
Surprisingly, inhibition of Src activity with the dominant
interfering Src mutant (Figure 5B) or treatment with Src
inhibitors (not shown) had no effect on Rac activity.
Downstream signaling to the Rac effector PAK was simi-
larly unaffected by Src inhibition (data not shown). Thus
the elevated Rac activity in C8161.9 cells is not due to ele-
vated Src activity.
PKC activity was inhibited in C8161.9 cells, either by long
term treatment with TPA to inhibit PKC expression (Fig-
ure 5C) or with the catalytic inhibitor bisindolylmaleim-
ide, and the effect on Rac activation after plating on VN
was analyzed. Inhibition of PKC resulted in reduced Rac
activity (Figure 5D) and reduced activation of the Rac
effector PAK (Figure 5E). To determine which PKC iso-
form, PKCα or PKCδ, was responsible for regulating Rac
activity an siRNA approach was used. Transient transfec-
t i o n  o f  s i R N A s  s p e c i f i c  t o  P K C α or PKCδ specifically
inhibited their respective expression, while the scrambled
siRNA had no effect on either PKC isoform (Figure 5C).
Inhibition of expression was maximal at 72 hours and
remained sustained for up to at least 144 hours (data not
shown). None of the siRNAs had any effect on PKCε. Inhi-
bition of PKCα, but not PKCδ, expression in C8161.9 cells
by PKC siRNAs dramatically reduced Rac activity (Figure
5D). Loss of PKCα, but not PKCδ, also reduced VN-
induced PAK activity (Figure 5E). Thus, PKCα is required
for activation of Rac and its downstream effector PAK in
C8161.9 cells.
Interestingly, Rac activity was often elevated in suspension
cells (Figure 5B, D), while PAK activity was not (Figure 5E)
suggesting an apparent disconnect between these two
molecules. However, previous studies have demonstrated
that the ability of Rac to signal to PAK is dependent on cell
adhesion [37]. The ability of Rac to activate PAK is
dependent on membrane translocation of Rac, which
requires an integrin-dependent adhesion event. Thus,
even though Rac is sometimes highly active in suspended
C8161.9 cells, it cannot complete the circuit to signal to
PAK in the absence of integrin engagement.
Both PKCα and PKCδ contribute to invasion
Inhibition of Src was sufficient to induce stress fibers and
increase focal adhesion formation in C8161.9 cells adher-
ent to VN (see Figure 3C). Inhibition of PKCα expression
Src activation prevents RhoA-dependent formation of stress fibers and focal adhesions Figure 3 (see previous page)
Src activation prevents RhoA-dependent formation of stress fibers and focal adhesions. A) C8161.9, M14, or nor-
mal cultured melanocytes (NHEM) were plated on fibronectin (FN) or vitronectin (VN) for 2 hours and the extent of stress 
fiber formation was monitored by staining with phalloidin (red). Focal adhesion formation was monitored by immunostaining 
with paxillin antibodies (green). Cells were counterstained with Hoescht to detect nuclei (blue). B) C8161.9 cells were tran-
siently transfected with GFP expressing plasmid and an active form of RhoA (Q61L). Cells were plated on vitronectin for 2 
hours and stained with phalloidin (red) to monitor actin structures in GFP-positive transfected (green) cells. Only the three 
cells expressing green GFP (i.e. transfected with RhoA (Q61L)) displayed prominent stress fibers. The nuclei of cells not 
expressing GFP/RhoA Q61L are marked by asterisks. C) C1861.9 cells were left untreated (control), treated with SU6656, or 
infected with dominant interfering mutant Src (K295M) virus. Cells were plated on vitronectin for 2 hours and stress fiber for-
mation monitored by staining with phalloidin (red) and focal adhesion formation by immunostaining with paxillin antibodies 
(green).Cell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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Src negatively regulates RhoA activity in C8161.9 cells Figure 4
Src negatively regulates RhoA activity in C8161.9 cells. A, C) C8161.9 cells were left untreated, treated with SU6656 
(SU), or B, D) infected with no virus (control), wild type Src (WT Src), or dominant interfering mutant Src (SrcK295M) virus. 
Cells were then placed in suspension (S) or plated on vitronectin (VN) for 45 minutes. A, B) the amount of GTP-bound RhoA 
(RhoAGTP) was monitored using GST-RBD pull-down assays (RBD IP) and immunoblotting. Total levels of RhoA and over 
expressed Src in the cell extracts were monitored by immunoblotting (RhoA Blot, Src Blot). Extent of RhoA activation was 
normalized to total RhoA for each sample. Data were expressed as the fold in increase in RhoA activation compared to con-
trol or untreated samples. C, D) The level of p190RhoGAP tyrosine phosphorylation was measured by immunoblotting of 
immunoprecipitates (p190GAP IP) with anti-phosphotyrosine antibodies (P-Tyr Blot). Total levels of p190RhoGAP in the 
immunoprecipitates were measured by immunoblotting with anti-p190RhoGAP antibodies (p190GAP Blot).Cell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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Figure 5 (see legend on next page)Cell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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by siRNA increased focal adhesion formation, but only
partially restored stress fibers – mostly around the nucleus
(Figure 6A). Inhibition of PKCδ primarily increased stress
fibers, with some increase in the size, but not number of
focal adhesions. However, neither response was as strong
as seen with inhibition of Src (see Figure 3C). Thus PKCα
appears to more strongly influence focal adhesions, while
PKCδ primarily targets stress fibers.
To delineate which PKC isoform is required for αvβ3-
mediated melanoma invasion, C8161.9 cells were trans-
fected with scrambled or PKC isoform-specific siRNAs to
inhibit PKC expression (Figure 6B) and tested for their
ability to invade VN-enriched Matrigel. Loss of PKCδ
resulted in a slight (20%), but consistently reproducible
decrease in invasion (Figure 6C). Loss of PKCα resulted in
a 2-fold decrease in Matrigel invasion (Figure 6C).
Src, PKCα, or PKCδ was over expressed in M14 cells to
determine if Src and PKC are sufficient to convert αvβ3-
expressing M14 cells to an invasive phenotype (Figure
6D). Over expression of PKCα or PKCδ alone was not suf-
ficient to induce M14 cell invasion of VN-enriched
Matrigel (Figure 6E). However, over expression of Src
alone or both PKCα and PKCδ increased M14 invasive-
ness 1.6- and 2-fold respectively.
Discussion
Increased expression of αvβ3 integrin correlates with
increased invasiveness and metastasis of melanoma in vivo
[2]. Here we demonstrate that αvβ3 integrin expressed on
the cell surface is not sufficient to generate invasive cells.
Normal cultured primary melanocytes and one
melanoma cell line both express αvβ3, yet they are not
invasive. Efficient αvβ3-mediated invasion of the highly
metastatic melanoma cell line C8161.9 requires at least
two additional biochemical alterations; elevated Src activ-
ity and elevated expression of PKCα and PKCδ. In addi-
tion, over expression of Src or co-expression of PKCα and
PKCδ is sufficient to convert the non-invasive αvβ3
integrin-expressing M14 cells to an invasive phenotype.
αvβ3 integrin binding to its vitronectin ligand is known to
activate both PKC and Src [11,45]. So why would invasive
melanoma cells require more Src and/or PKC activity if
αvβ3 integrin is sufficient to activate these two pathways?
It is possible that the sustained activity of PKC and/or Src
signaling (and their inability to be turned off) is necessary
to keep αvβ3 integrin signaling turned on long enough for
effective invasion. The β3 integrin subunit is known to
undergo a conformational change that enhances cell
adhesion via mechanism termed 'inside-out' signaling
and PKC has been shown to be important for αIIbβ3 acti-
vation in platelets [46]. An antibody that recognizes the
activated form of β3 integrin has been described [47].
However, we failed to detect any difference in αvβ3
integrin activation state between C1861.9 or M14 cells
using this antibody (data not shown). Thus increased sig-
naling through PKC and Src does not increase invasive-
ness by altering inside-out signaling in these cells.
Another possibility is that sustained signaling is required
for enhanced secretion and activation of matrix metallo-
proteases (MMPs) required for movement through the
ECM. Both Src and PKC are known to control MMP activ-
ity, and C8161.9 cells are known to have high levels of
MMP activity [48], while M14 cells have low activity [49].
Conversely, elevated Src and PKC activity alone would not
be sufficient for invasion, because the cells need the
integrin to engage the substrate and localize proteases to
facilitate movement.
At first glance it would appear that our findings contradict
previous studies in which αvβ3 integrin expression in
αvβ3 negative non-invasive melanomas was sufficient to
generate invasive melanomas [5]. However, the status of
PKC and Src signaling in those cells was not evaluated.
Thus, it is possible that PKC or Src were already elevated
or active in those cells and the addition of αvβ3 was all
PKCα positively regulates Rac activity in C1861.9 cells Figure 5 (see previous page)
PKCα positively regulates Rac activity in C1861.9 cells. A) C8161.9 or M14 cells were placed in suspension (S), plated 
on vitronectin (VN) for 45 minutes, or confluent cells were serum starved and then stimulated with 40 uM IGF (IGF) for 5 min-
utes. The level of GTP-bound Rac (RacGTP) was measured using GST-PBD pull-down assays (PBD IP) and immunoblotting for 
Rac activity. Total levels of Rac were monitored by immunoblotting of whole cell extracts (Rac Blot). B) C8161.9 cells unin-
fected (control) or infected with wild type (WT Src) or dominant interfering Src mutant (SrcKM) virus were treated and plated 
as in A) and analyzed for Rac activation (PBD IP). C) C8161.9 cells were pretreated with DMSO, TPA for 16 hours, or bisin-
dolylmaleimide (Bis). Or cells were transfected with nothing (C), scrambled (Scr), PKCα (iPKα), or PKCδ (iPKδ) siRNA and 
the total levels of PKCα, PKCδ, and PKCε were monitored by immunoblotting. Total levels of protein were monitored by 
immunoblotting for tubulin. D) C8161.9 cells were treated with DMSO or bisindolylmaleimide, or transfected with scrambled 
(Scr), PKCα (iPKα), or PKCδ (iPKδ) siRNA and their ability to activate Rac (PBD IP) in suspension (S) or after plating on vit-
ronectin (VN) was assessed as in A). E) Cells were treated as in D) and PAK activation was measured by immunoblotting of 
whole cell lysates with anti-phospho-PAK antibody that recognizes the activated form of PAK (P-PAK Blot). Total levels of 
PAK in the cell lysates were monitored by immunoblotting with anti-PAK antibodies (PAK Blot).Cell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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they needed. Another possibility is that because the αvβ3
reconstitution assays were carried out under serum and
growth factor stimulatory conditions (which was absent
from our in vitro assays), the presence of exogenous fac-
tors were sufficient to generate the PKC and/or Src signal-
ing events needed to sustain αvβ3-mediated invasion.
Our studies have focused only on αvβ3 integrin and its
ligand vitronectin. We can't rule out the possibility that
other integrins binding other matrices might work just as
effectively at promoting invasion in the context of ele-
vated PKC and Src signaling. C8161.9 cells will not invade
Matrigel (primarily a laminin-based substrate) that has
not been treated with vitronectin. Thus laminin integrins
are not sufficient for invasion even when PKC levels and
Src activity are elevated. C8161.9 cells will invade Matrigel
that has been treated with fibronectin (data not shown).
We have not determined if this is solely due αvβ3 or
whether another RGD integrin such as α5β1 is also
involved. Others have reported that α5β1 integrin can reg-
ulate melanoma invasion on fibronectin [48]; however,
the signaling pathways involved in α5β1-dependent inva-
sion were not investigated. In the complex microenviron-
ment found within a tumor-containing tissue, it is quite
possible that several integrins may function together to
facilitate invasion. We have delineated at least one possi-
ble mechanism by which αvβ3 integrin bound to its pri-
mary ligand vitronectin facilitates invasion.
In vivo studies demonstrating notable changes in Src
expression levels or activity have rarely been reported in
human melanoma samples. Nonetheless, increased Src
kinase levels and activity in several cultured melanoma
cell lines have been frequently reported and Src activity
was shown to contribute to the formation of invasive
posodomal structures that are prominently seen in vivo in
melanoma samples [18]. That Src may contribute to αvβ3-
mediated invasion and metastasis is not surprising given
the known role that Src has been shown to play in many
integrin-dependent events. Our ability to cause non-inva-
sive melanoma cells to become invasive by Src over
expression and to reduce invasion of highly invasive cells
by inhibiting Src, was also observed in a study comparing
the highly metastatic K1735M2 melanoma cells to the
poorly metastatic K1735C23 [19]. In the K1735 cells inva-
sion was linked to αvβ3 integrin expression and FAK acti-
vation, a known Src substrate. We have found that another
effect of increased Src signaling in metastatic melanoma
cells is to suppress RhoA activity, through Src-dependent
phosphorylation and activation of one of Rho's negative
regulators, p190RhoGAP.
Our results strongly support the previous finding that
PKCα over expression is important for melanoma metas-
tasis  in vivo [21] and that loss of PKCδ suppresses
melanoma metastatic potential [25]. In addition, elevated
PKCα and PKCδ levels have been detected in metastatic
melanoma cells taken from lymph nodes of patients
[50,51]. Here we demonstrate that the high expression of
PKCα, but not PKCδ, in C8161.9 human melanoma cells
facilitates αvβ3-dependent invasion through regulation of
Rac and activation of PAK and limiting focal adhesion for-
mation. PKCδ, on the other hand, appears to limit stress
fiber formation.
The link between integrins, PKC, and Rac activation is a
new finding. However, a recent study demonstrated that
syndecan 4-dependent cell migration was dependent on
the ability of PKCα to activate Rac [52]. As in our system,
this was unique to PKCα, in that loss of PKCδ or PKCε had
no effect on Rac. The mechanism by PKCα regulates Rac
activity has yet to be determined, but may involve regula-
tion of Rac GEFs or GAPs. Two other Rac/PKC relation-
ships have recently been reported. In colon cancer cells
Rac signaling to PAK controls PKC/fascin interactions to
regulate their migration, and spingosine1P signaling to
PKCε subsequently activates a PLD2-PKCζ-Rac1 cascade
to stimulate migration of endothelial cells [53,54]. Thus
there may be several ways to interface PKC and Rac sign-
aling to regulate motility in cells.
Both PKCα and PKCδ are required for αvβ3-mediated invasion Figure 6 (see previous page)
Both PKCα and PKCδ are required for αvβ3-mediated invasion. A) C8161.9 cells were transfected with scrambled 
(Scram), PKCδ siRNA (si1δ), or two PKCα siRNAs (si2α, si3α) and siRNA-transfected cells were plated on vitronectin for 2 
hours and the extent of stress fiber and focal adhesion formation was monitored by staining with phalloidin (red) and immu-
nostaining with anti-paxillin (green) respectively. Nuclei were counterstained with Hoescht (blue). White arrows indicate actin 
stress fibers around the perinuclear area in PKCα siRNA-treated cells. B) C8161.9 cells were transfected with scrambled (Sc), 
PKCδ (i1δ), si2α PKCα (i2α), or si3α PKCα (i3α) siRNAs. The levels of PKCα, PKCδ, and PKCε in siRNA transfected cells 
were measured by immunoblotting with isoform-specific PKC antibodies. Total levels of tubulin were also monitored (tubulin). 
C) C8161.9 cells were transfected with scrambled (Sc), PKCα siRNAs si3α (si3a), si2α (si2a), or PKCδ siRNA (si1d) and tested 
for their ability to invade VN-enriched Matrigel. Data represents at least 4 independent experiments. D) M14 cells were 
infected with viruses expressing nothing (V), PKCα (α), PKCδ (δ), Src, or PKCα and PKCδ (α + δ). Total levels of each protein 
were monitored by immunoblotting. E) Ability of the over expressing M14 cells to invade VN-enriched Matrigel was moni-
tored. Data represents 3 independent experiments.Cell Communication and Signaling 2009, 7:10 http://www.biosignaling.com/content/7/1/10
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Even though PKCδ was not involved in regulating Rac/
PAK signaling in our melanoma cells, it nonetheless con-
tributes to efficient invasion. Loss of PKCδ only partially
blocks invasion of C8161.9 cells, while over expression of
both PKCα and PKCδ in non-invasive M14 cells was
required to induce invasion. The differential ability of
PKCδ and PKCα to regulate stress fibers versus focal adhe-
sion formation respectively indicates that each PKC iso-
form contributes differently to actin remodeling, which is
consistent with differential affects of each PKC isoform on
Rac activation and the need for both isoforms to induce
M14 cell invasion. Src has the ability to control both stress
fibers and focal adhesions and is sufficient to induce inva-
sion of M14 cells. The inability to completely restore stress
fibers and focal adhesion upon inhibition of PKCs sug-
gests Src is still able to exert some of its effects. Conversely,
loss of Src alone is not sufficient to completely inhibit
invasion of the C8161.9 cells, presumably because PKCs
are still active. Together our data suggest some level of
cooperation between PKCs and Src in optimally enhanc-
ing invasion by balancing the formation of adhesion
structures and regulation of motility through differential
regulation of Rac and RhoA.
Our studies have focused on the small GTPases RhoA and
Rac, because of their known involvement in regulating the
specific actin arrangements we observed in C8161.9 cells.
Gene expression analyses of metastatic melanoma have
consistently identified RhoC as a major component of
metastatic melanoma in vivo [55,56]. However, in isolated
cell lines grown in culture, RhoC expression is rarely
detected. Thus the unique microenvironment generated in
vivo appears to favor RhoC expression, which has been
demonstrated to be required for metastasis in vivo. We did
not detect RhoC expression in C8161.9 cells and RhoC
was not detected in our Rhotekin pull-down assays (data
not shown). One study demonstrated that over expression
of RhoC in a radial growth phase melanoma cell line,
WM35, promoted cell invasion and increased signaling
through the PI-3K/Akt pathway, independent of signaling
through the RhoA downstream effector ROCK [57].
Whether the effects of RhoC on in vitro invasiveness or in
vivo metastasis are linked to αvβ3 remains to be deter-
mined.
Conclusion
Elevated expression levels of PKCα and PKCδ, as well as
constitutively high Src activity in highly metastatic
melanoma cells are critical for optimal αvβ3-dependent
invasion. Over expression of Src or co-expression of PKCα
and PKCδ is sufficient to convert αvβ3-expressing non-
invasive melanoma cells to highly invasive cells. Src is
responsible for suppressing αvβ3-dependent activation of
RhoA via stimulation of p190RhoGAP, while PKCα is
required for Rac-dependent activation of PAK. PKCα pre-
dominantly represses focal adhesion formation, while
PKCδ represses stress fibers. The net effect of the com-
bined action of PKC and Src is to increase the levels of Rac
activity relative to RhoA, which inhibits stress fiber forma-
tion and reduces focal adhesion and cell attachment
favoring a more migratory phenotype required for αvβ3-
dependent invasion.
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